Trial Profile
Assessment of association efficacy of colinergic precursor and cholinesterasic inhibitor somministered transdermal in patient with Alzheimer`s disease and severe behavioural disturbances
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2012
Price :
$35
*
At a glance
- Drugs Choline alfoscerate (Primary) ; Acetylcholinesterase inhibitors
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms ASCOTALCO
- 22 Mar 2012 New trial record